• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.89% Nasdaq Up 0.60%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    10.84 Up 0.15(1.40%) 10:32AM EDT - Nasdaq Real Time Price
    Prev Close:10.69
    Open:10.77
    Bid:10.93 x 200
    Ask:10.96 x 100
    1y Target Est:24.50
    Beta:2.18937
    Earnings Date:Aug 4 - Aug 8 (Est.)
    Day's Range:10.52 - 10.98
    52wk Range:8.27 - 28.48
    Volume:52,223
    Avg Vol (3m):336,365
    Market Cap:620.29M
    P/E (ttm):N/A
    EPS (ttm):-2.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EPZM

    Comparison

    Symbol% ChgMkt Cap
    EPZMUp 1.40%620.29M
    GSKUp 0.72%104.49B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):288.40
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-2.19
    Quarterly EPS Est (Jun-16) :-0.51
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. The company’s proprietary product platform creates small molecule inhibitors of enzymes known as histone methyltransfe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback